Parvaquone
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101676This classification denotes an antimalarial agent with the molecular formula C16H16O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A2BH18685W, chemically known as 1,4-naphthalenedione, 2-cyclohexyl-3-hydroxy- but generally known as parvaquone, which bears US NIH Compound Identifier 71825. European Medicines Agency schedules Parvaquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09634MIG. The term PARVAQUONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PARVAQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule parvaquone under HS 29146990 and SITC 51629. As of Q4 2014, PARVAQUONE remains the US FDA Preferred Term for this commodity. Parvaquone bears US NLM identifiers UMLS ID C0070129 and NCI Concept Code C66327. SMILES: OC1=C(C2CCCCC2)C(=O)C(=O)C2C1CCCC2.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.